Jonathan M Roselman, MD
Hospice/Palliative Care · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Roselman’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Illinois 036147656Licensed Physician And Surgeon · since 2018 · expires 2026-08-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$9,913
Medicare paid this office $9,913 for 57 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,411 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,075 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $963 | $60 |
Who their Medicare patients are
57 Original Medicare patients in 2024. Average age 65 · Under 65 32% · Women 74% · Also on Medicaid 49% · Health risk score 3.18. Above the middle of the specialty; the typical hospice and palliative care clinician is at 2.98.
Conditions among them: High blood pressure 75% · Coronary heart disease 47% · Chronic kidney disease 47% · Diabetes 40% · Heart failure 39% · Depression 39% · Cancer 35% · Atrial fibrillation 26% · COPD 25% · Stroke 19%.
The office billed $31,558, Medicare allowed $13,718 and paid $9,913; for 115 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 57 | 115 | 65 | 3.18 | $31,558 | $9,913 |
| 2023 | 133 | 325 | 65 | 4.27 | $84,245 | $30,374 |
| 2022 | 154 | 409 | 66 | 4.48 | $107,527 | $37,090 |
| 2021 | 188 | 612 | 67 | 4.11 | $166,558 | $58,824 |
| 2020 | 163 | 491 | 66 | 4.43 | $148,044 | $48,482 |
| 2019 | 174 | 406 | 65 | 4.05 | $112,707 | $36,352 |
| 2018 | 13 | 17 | 65 | 2.93 | $4,289 | $1,483 |
| 2017 | 11 | 12 | 79 | 2.90 | $2,162 | $1,589 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $13,012 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,812 | $112 |
| Long return visit (40+ min) | 24 | $3,688 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $3,451 | $64 |
| Return visit (30+ min) | 17 | $1,646 | $78 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $14,021 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,104 | $114 |
| Long return visit (40+ min) | 23 | $4,023 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,716 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,435 | $61 |
| Return visit (30+ min) | 21 | $2,191 | $76 |
2021: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $26,030 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,719 | $172 |
| Long return visit (40+ min) | 24 | $4,355 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,091 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,018 | $118 |
| Long return visit (40+ min) | 14 | $2,070 | $138 |
| Return visit (30+ min) | 19 | $2,049 | $82 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,749 | $87 |
| Advance care planning, first 30 minutes | 15 | $1,015 | $68 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $23,867 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $10,807 | $174 |
| Long return visit (40+ min) | 23 | $3,312 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,013 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,431 | $62 |
| Return visit (30+ min) | 22 | $1,807 | $69 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,152 | $64 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $10,344 | $88 |
| Long return visit (40+ min) | 56 | $8,056 | $94 |
| Return visit (30+ min) | 47 | $4,289 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,269 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,499 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,555 | $116 |
| New patient visit (45+ min) | 11 | $1,208 | $110 |
Medicaid work
$2,131 in 2024
Medicaid paid $2,131 for 32 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 32 | $2,131 |
| 2024 | 32 | 1 | 15 | $2,131 |
| 2023 | 88 | 2 | 20 | $4,368 |
| 2022 | 189 | 1 | 18 | $9,361 |
| 2021 | 657 | 1 | 24 | $27,715 |
| 2020 | 400 | 1 | 30 | $16,263 |
| 2019 | 83 | 3 | 20 | $4,707 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 76 | $3,551 |
| Long return visit (40+ min) | 12 | $817 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 189 | $9,361 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 657 | $27,715 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 400 | $16,263 |
2019
| Long return visit (40+ min) | 35 | $2,410 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 36 | $1,706 |
| Return visit (30+ min) | 12 | $592 |
Drugs they prescribed that Part D paid
$22,490
Pharmacies billed $22,490 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 45% of their Part D prescriptions (105 of 232) in 2024. Above the middle of the specialty; the typical hospice and palliative care clinician is at 43%. Long-acting opioids: 50% of their opioid prescriptions.
209 generic and 23 brand-name prescriptions · $22,490 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 22 | $5,894 | $268 |
| Buprenorphine-Naloxone | 11 | $2,392 | $217 |
| Gabapentin | 40 | $920 | $23 |
| Pregabalin | 21 | $573 | $27 |
| Oxycodone | 22 | $355 | $16 |
See all 6 drugs
| Buprenorphine | 22 | $5,894 | $268 |
| Buprenorphine-Naloxone | 11 | $2,392 | $217 |
| Gabapentin | 40 | $920 | $23 |
| Pregabalin | 21 | $573 | $27 |
| Oxycodone | 22 | $355 | $16 |
| Duloxetine | 22 | $185 | $8 |
Year by year
| 2024 | 232 | 78 | 45% (105) | 10% | $22,490 |
| 2023 | 431 | 147 | 46% (199) | 11% | $37,759 |
| 2022 | 570 | 154 | 47% (266) | 11% | $33,609 |
| 2021 | 472 | 151 | 54% (256) | 10% | $27,091 |
| 2020 | 517 | 135 | 49% (251) | 11% | $38,671 |
| 2019 | 691 | 140 | 48% (329) | 15% | $73,803 |
| 2018 | 31 | 19 | None | None | $1,541 |
| 2017 | 186 | 35 | 0% (0) | 21% | $11,733 |
| 2016 | 33 | 20 | 0% (0) | None | $952 |
| 2015 | 90 | 38 | 0% (0) | 21% | $4,206 |
| 2014 | 29 | None | 0% (0) | 55% | $3,222 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Buprenorphine | 36 | $11,835 | $329 |
| Fentanyl | 18 | $1,866 | $104 |
| Pregabalin | 39 | $1,601 | $41 |
| Duloxetine | 43 | $1,333 | $31 |
| Hydromorphone | 28 | $1,309 | $47 |
| Gabapentin | 58 | $1,175 | $20 |
| Hydrocodone-Acetaminophen | 36 | $842 | $23 |
| Oxycodone | 26 | $696 | $27 |
| Morphine Sulfate Er | 17 | $437 | $26 |
| Tizanidine | 12 | $114 | $10 |
2022: 11 drugs
| Hydromorphone | 50 | $3,870 | $77 |
| Pregabalin | 51 | $2,666 | $52 |
| Hydrocodone-Acetaminophen | 76 | $2,294 | $30 |
| Gabapentin | 82 | $2,138 | $26 |
| Duloxetine | 50 | $2,098 | $42 |
| Morphine Sulfate Er | 49 | $2,040 | $42 |
| Lidocaine | 17 | $1,854 | $109 |
| Fentanyl | 18 | $1,366 | $76 |
| Morphine Sulfate | 15 | $1,172 | $78 |
| Oxycodone | 26 | $660 | $25 |
| Tizanidine | 12 | $89 | $7 |
2021: 10 drugs
| Fentanyl | 39 | $2,743 | $70 |
| Lidocaine | 20 | $2,476 | $124 |
| Hydromorphone | 43 | $2,196 | $51 |
| Hydrocodone-Acetaminophen | 72 | $2,131 | $30 |
| Gabapentin | 57 | $1,825 | $32 |
| Morphine Sulfate Er | 34 | $1,472 | $43 |
| Duloxetine | 28 | $1,168 | $42 |
| Morphine Sulfate | 16 | $1,150 | $72 |
| Pregabalin | 29 | $1,103 | $38 |
| Oxycodone | 24 | $856 | $36 |
2020: 13 drugs
| Lidocaine | 18 | $5,099 | $283 |
| Fentanyl | 30 | $3,210 | $107 |
| Pregabalin | 28 | $2,848 | $102 |
| Hydromorphone | 39 | $2,555 | $66 |
| Hydrocodone-Acetaminophen | 73 | $2,028 | $28 |
| Gabapentin | 58 | $1,954 | $34 |
| Duloxetine | 65 | $1,843 | $28 |
| Morphine Sulfate | 26 | $1,517 | $58 |
| Morphine Sulfate Er | 29 | $1,161 | $40 |
| Oxycodone | 20 | $525 | $26 |
| Ondansetron | 12 | $361 | $30 |
| Mirtazapine | 14 | $191 | $14 |
| Nortriptyline | 11 | $83 | $8 |
2019: 15 drugs
| Oxycontin | 19 | $13,860 | $729 |
| Lyrica | 21 | $12,953 | $617 |
| Hydromorphone | 50 | $4,471 | $89 |
| Gabapentin | 113 | $3,769 | $33 |
| Duloxetine | 65 | $3,732 | $57 |
| Hydrocodone-Acetaminophen | 93 | $3,409 | $37 |
| Fentanyl | 30 | $2,871 | $96 |
| Lidocaine | 26 | $2,623 | $101 |
| Pregabalin | 15 | $1,808 | $121 |
| Morphine Sulfate Er | 46 | $1,664 | $36 |
| Morphine Sulfate | 25 | $1,240 | $50 |
| Oxycodone | 24 | $872 | $36 |
| Tramadol | 23 | $167 | $7 |
| Mirtazapine | 14 | $116 | $8 |
| Nortriptyline | 11 | $81 | $7 |
2017: 6 drugs
| Aspirin-Dipyridamole Er | 11 | $3,149 | $286 |
| Duloxetine | 16 | $399 | $25 |
| Atorvastatin | 20 | $180 | $9 |
| Levothyroxine | 13 | $149 | $11 |
| Pramipexole Dihydrochloride | 11 | $108 | $10 |
| Omeprazole | 11 | $52 | $5 |
Professional record
- NPI
- 1639584030
- Licence
- IL 036-147656Illinois 036147656: Active
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0002X (207RH0002X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-06-24
- NPI last updated
- 2025-07-01
- NPI record certified
- 2025-07-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1750 W Harrison St, Chicago, IL, 60612 · 501 Madison Ave, Scranton, PA, 18510